Literature DB >> 28971215

[Differential indications of opioids in pain therapy].

J Heyn1, S C Azad2.   

Abstract

Due to their strong analgesic potency opioids are highly effective in the therapy of acute and particularly cancer-induced chronic pain; however, the individual opioids differ considerably with respect to their pharmacokinetic and physicochemical properties and may therefore not be equally applicable for every patient. Caution should be taken especially in patients with impaired organ function. Furthermore, the metabolism of opioids leads to active or inactive metabolites. This process can be substantially influenced by genetic polymorphisms or drug interactions. Knowledge of all these factors for individual opioids, which influence the efficacy and side effects, is therefore crucial. In this review the pharmacology, clinical applications, metabolism and genetic factors of the most important opioids used for pain management are discussed.

Entities:  

Keywords:  Analgesia; Hepatic failure; Opioids; Pharmacology; Renal failure

Mesh:

Substances:

Year:  2017        PMID: 28971215     DOI: 10.1007/s00101-017-0369-2

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  67 in total

1.  THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. II. SOLUBILIZATION, PURIFICATION, AND PROPERTIES.

Authors:  T OMURA; R SATO
Journal:  J Biol Chem       Date:  1964-07       Impact factor: 5.157

2.  Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population.

Authors:  Maria Gabriella Scordo; Achille P Caputi; Concetta D'Arrigo; Giuseppina Fava; Edoardo Spina
Journal:  Pharmacol Res       Date:  2004-08       Impact factor: 7.658

3.  Nomenclature for human CYP2D6 alleles.

Authors:  A K Daly; J Brockmöller; F Broly; M Eichelbaum; W E Evans; F J Gonzalez; J D Huang; J R Idle; M Ingelman-Sundberg; T Ishizaki; E Jacqz-Aigrain; U A Meyer; D W Nebert; V M Steen; C R Wolf; U M Zanger
Journal:  Pharmacogenetics       Date:  1996-06

4.  Separation of five major alkaloids in gum opium and quantitation of morphine, codeine, and thebaine by isocratic reverse phase high performance liquid chromatography.

Authors:  C Y Wu; J J Wittick
Journal:  Anal Chem       Date:  1977-03       Impact factor: 6.986

5.  Frequent distribution of ultrarapid metabolizers of debrisoquine in an ethiopian population carrying duplicated and multiduplicated functional CYP2D6 alleles.

Authors:  E Aklillu; I Persson; L Bertilsson; I Johansson; F Rodrigues; M Ingelman-Sundberg
Journal:  J Pharmacol Exp Ther       Date:  1996-07       Impact factor: 4.030

6.  Opioid mu, delta, and kappa receptor-induced activation of phospholipase C-beta 3 and inhibition of adenylyl cyclase is mediated by Gi2 and G(o) in smooth muscle.

Authors:  K S Murthy; G M Makhlouf
Journal:  Mol Pharmacol       Date:  1996-10       Impact factor: 4.436

7.  [Incidence of constipation in patients with outpatient opioid therapy].

Authors:  S Tafelski; T Beutlhauser; F Bellin; E Reuter; T Fritzsche; C West; M Schäfer
Journal:  Schmerz       Date:  2016-04       Impact factor: 1.107

Review 8.  [Recommendations of the updated LONTS guidelines. Long-term opioid therapy for chronic noncancer pain].

Authors:  W Häuser; F Bock; P Engeser; G Hege-Scheuing; M Hüppe; G Lindena; C Maier; H Norda; L Radbruch; R Sabatowski; M Schäfer; M Schiltenwolf; M Schuler; H Sorgatz; T Tölle; A Willweber-Strumpf; F Petzke
Journal:  Schmerz       Date:  2015-02       Impact factor: 1.107

9.  Long-term opioid therapy for chronic non-cancer pain in Germany.

Authors:  U Marschall; H L'hoest; L Radbruch; W Häuser
Journal:  Eur J Pain       Date:  2015-10-22       Impact factor: 3.931

Review 10.  P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature.

Authors:  D R Nelson; L Koymans; T Kamataki; J J Stegeman; R Feyereisen; D J Waxman; M R Waterman; O Gotoh; M J Coon; R W Estabrook; I C Gunsalus; D W Nebert
Journal:  Pharmacogenetics       Date:  1996-02
View more
  1 in total

1.  [The right opioid for my patient].

Authors:  M Schäfer
Journal:  Anaesthesist       Date:  2017-11       Impact factor: 1.041

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.